Mechanical stress and the arterial wall

Blood Pressure and Arterial Wall Mechanics in Cardiovascular Diseases

Volumn 9781447151982, Issue , 2014, Pages 97-106

  Schiffrin, Ernesto L ^a   Tedgui, Alain ^b   Lehoux, Stephanie ^a  

^a MCGILL UNIVERSITY   (Canada)

^b INSERM   (France)

Author keywords

Circumferential strain; Collagen; Elastin; Extracellular matrix; Hypertension; Matrix metalloproteinases

Indexed keywords

EID: 84949178594     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4471-5198-2_9     Document Type: Chapter

References (75)

1. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, infl ammation, and fi brosis. Hypertension. 2001;38(3 Pt 2):581-7.
2. Lemarie CA, Tharaux PL, Lehoux S. Extracellular matrix alterations in hypertensive vascular remodeling. J Mol Cell Cardiol. 2009;48(3):433-9.
3. Hu JJ, Ambrus A, Fossum TW, Miller MW, Humphrey JD, Wilson E. Time courses of growth and remodeling of porcine aortic media during hypertension: a quantitative immunohistochemical examination. J Histochem Cytochem. 2008;56(4):359-70.
4. O'Rourke MF. Arterial aging: pathophysiological principles. Vasc Med. 2007;12(4):329-41.
5. O'Rourke MF, Hashimoto J. Mechanical factors in arterial aging: a clinical perspective. J Am Coll Cardiol. 2007;50(1):1-13. Epub 2007/07/03.
6. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37(5):1236-41.
7. Blacher J, Safar ME, Guerin AP, Pannier B, Marchais SJ, London GM. Aortic pulse wave velocity index and mortality in end-stage renal disease. Kidney Int. 2003;63(5):1852-60.
8. Stork S, van den Beld AW, von Schacky C, Angermann CE, Lamberts SW, Grobbee DE, et al. Carotid artery plaque burden, stiffness, and mortality risk in elderly men: a prospective, population-based cohort study. Circulation. 2004;110(3):344-8.
9. Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation. 2006;113(5):657-63.
10. Hajdu MA, Baumbach GL. Mechanics of large and small cerebral arteries in chronic hypertension. Am J Physiol. 1994;266(3 Pt 2):H1027-33. Epub 1994/03/01.
11. Intengan HD, Schiffrin EL. Mechanical properties of mesenteric resistance arteries from Dahl salt-resistant and salt-sensitive rats: role of endothelin-1. J Hypertens. 1998;16(12 Pt 2):1907-12. Epub 1999/01/14.
12. Intengan HD, He G, Schiffrin EL. Effect of vasopressin antagonism on structure and mechanics of small arteries and vascular expression of endothelin-1 in deoxycorticosterone acetate salt hypertensive rats. Hypertension. 1998;32(4):770-7. Epub 1998/10/17.
13. Intengan HD, Thibault G, Li JS, Schiffrin EL. Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats: effects of angiotensin receptor antagonism and converting enzyme inhibition. Circulation. 1999; 100(22):2267-75.
14. Intengan HD, Deng LY, Li JS, Schiffrin EL. Mechanics and composition of human subcutaneous resistance arteries in essential hypertension. Hypertension. 1999;33(1 Pt 2):569-74.
15. Sharifi AM, Li JS, Endemann D, Schiffrin EL. Effects of enalapril and amlodipine on small-Artery structure and composition, and on endothelial dysfunction in spontaneously hypertensive rats. J Hypertens. 1998; 16(4):457-66.
16. Thybo NK, Mulvany MJ, Jastrup B, Nielsen H, Aalkjaer C. Some pharmacological and elastic characteristics of isolated subcutaneous small arteries from patients with essential hypertension. J Hypertens. 1996;14(8):993-8. Epub 1996/08/01.
17. Faury G, Pezet M, Knutsen RH, Boyle WA, Heximer SP, McLean SE, et al. Developmental adaptation of the mouse cardiovascular system to elastin haploinsufficiency. J Clin Invest. 2003;112(9):1419-28.
18. Chamiot Clerc P, Renaud JF, Blacher J, Legrand M, Samuel JL, Levy BI, et al. Collagen I and III and mechanical properties of conduit arteries in rats with genetic hypertension. J Vasc Res. 1999;36(2):139-46. Epub 1999/04/24.
19. Shekhonin BV, Domogatsky SP, Muzykantov VR, Idelson GL, Rukosuev VS. Distribution of type I, III, IV and V collagen in normal and atherosclerotic human arterial wall: immunomorphological characteristics. Coll Relat Res. 1985;5(4):355-68. Epub 1985/09/01.
20. Bashey RI, Cox R, McCann J, Jimenez SA. Changes in collagen biosynthesis, types, and mechanics of aorta in hypertensive rats. J Lab Clin Med. 1989;113(5):604-11. Epub 1989/05/01.
21. Bezie Y, Lamaziere JM, Laurent S, Challande P, Cunha RS, Bonnet J, et al. Fibronectin expression and aortic wall elastic modulus in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol. 1998; 18(7):1027-34.
22. Yong VW, Krekoski CA, Forsyth PA, Bell R, Edwards DR. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci. 1998;21(2):75-80. Epub 1998/03/14.
23. Xu C, Zarins CK, Pannaraj PS, Bassiouny HS, Glagov S. Hypercholesterolemia superimposed by experimental hypertension induces differential distribution of collagen and elastin. Arterioscler Thromb Vasc Biol. 2000;20(12):2566-72.
24. Castro CM, Cruzado MC, Miatello RM, Risler NR. Proteoglycan production by vascular smooth muscle cells from resistance arteries of hypertensive rats. Hypertension. 1999;34(4 Pt 2):893-6. Epub 1999/10/16.
25. Gandley RE, McLaughlin MK, Koob TJ, Little SA, McGuffee LJ. Contribution of chondroitin-dermatan sulfate-containing proteoglycans to the function of rat mesenteric arteries. Am J Physiol. 1997;273(2 Pt 2):H952-60. Epub 1997/08/01.
26. Marque V, Van Essen H, Struijker-Boudier HA, Atkinson J, Lartaud-Idjouadiene I. Determination of aortic elastic modulus by pulse wave velocity and wall tracking in a rat model of aortic stiffness. J Vasc Res. 2001;38(6):546-50.
27. Walker-Caprioglio HM, Koob TJ, McGuffee LJ. Proteoglycan synthesis in normotensive and spontaneously hypertensive rat arteries in vitro. Matrix. 1992;12(4):308-20. Epub 1992/08/01.
28. Lakatta EG. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging. Circulation. 2003;107(3):490-7.
29. Zanchi A, Wiesel P, Aubert JF, Brunner HR, Hayoz D. Time course changes of the mechanical properties of the carotid artery in renal hypertensive rats. Hypertension. 1997;29(5):1199-203. Epub 1997/05/01.
30. Laurant P, Touyz RM, Schiffrin EL. Effect of pressurization on mechanical properties of mesenteric small arteries from spontaneously hypertensive rats. J Vasc Res. 1997;34(2):117-25. Epub 1997/03/01.
31. Baumbach GL, Dobrin PB, Hart MN, Heistad DD. Mechanics of cerebral arterioles in hypertensive rats. Circ Res. 1988;62(1):56-64. Epub 1988/01/01.
32. Baumbach GL, Hajdu MA. Mechanics and composition of cerebral arterioles in renal and spontaneously hypertensive rats. Hypertension. 1993;21:816-26.
33. Galis ZS, Muszynski M, Sukhova GK, Simonmorrissey E, Unemori EN, Lark MW, et al. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res. 1994;75:181-9.
34. Palombo D, Maione M, Cifi ello BI, Udini M, Maggio D, Lupo M. Matrix metalloproteinases. Their role in degenerative chronic diseases of abdominal aorta. J Cardiovasc Surg (Torino). 1999;40(2):257-60. Epub 1999/06/01.
35. Asanuma K, Magid R, Johnson C, Nerem RM, Galis ZS. Uniaxial strain upregulates matrix-degrading enzymes produced by human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol. 2003; 284(5):H1778-84.
36. Grote K, Flach I, Luchtefeld M, Akin E, Holland SM, Drexler H, et al. Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidase-derived reactive oxygen species. Circ Res. 2003;92(11):e80-6.
37. Jackson ZS, Gotlieb AI, Langille BL. Wall tissue remodeling regulates longitudinal tension in arteries. Circ Res. 2002;90(8):918-25.
38. Lehoux S, Lemarie CA, Esposito B, Lijnen HR, Tedgui A. Pressure-induced matrix metalloproteinase-9 contributes to early hypertensive remodeling. Circulation. 2004;109(8):1041-7.
39. Flamant M, Placier S, Dubroca C, Esposito B, Lopes I, Chatziantoniou C, et al. Role of matrix metalloproteinases in early hypertensive vascular remodeling. Hypertension. 2007;50(1):212-8.
40. Yasmin, Wallace S, McEniery CM, Dakham Z, Pusalkar P, Maki-Petaja K, et al. Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness. Arterioscler Thromb Vasc Biol. 2005;25(2):372.
41. Diez J, Panizo A, Gil MJ, Monreal I, Hernandez M, Pardo Mindan J. Serum markers of collagen type I metabolism in spontaneously hypertensive rats: relation to myocardial fi brosis. Circulation. 1996;93(5):1026-32. Epub 1996/03/01.
42. Diez J, Laviades C, Mayor G, Gil MJ, Monreal I. Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations. Circulation. 1995;91(5):1450-6. Epub 1995/03/01.
43. Laviades C, Varo N, Fernandez J, Mayor G, Gil MJ, Monreal I, et al. Abnormalities of the extracellular degradation of collagen type I in essential hypertension. Circulation. 1998;98(6):535-40.
44. Kim S, Kawamura M, Wanibuchi H, Ohta K, Hamaguchi A, Omura T, et al. Angiotensin II type 1 receptor blockade inhibits the expression of immediate-early genes and fi bronectin in rat injured artery. Circulation. 1995;92:88-95.
45. Lee HW, Karam J, Hussain B, Winer N. Vascular compliance in hypertension: therapeutic implications. Curr Diab Rep. 2008;8(3):208-13.
46. Antonio RC, Ceron CS, Rizzi E, Coelho EB, Tanus-Santos JE, Gerlach RF. Antioxidant effect of doxycycline decreases MMP activity and blood pressure in SHR. Mol Cell Biochem. 2014;386:99-105.
47. Thyberg J, Blomgren K, Roy J, Tran PK, Hedin U. Phenotypic modulation of smooth muscle cells after arterial injury is associated with changes in the distribution of laminin and fi bronectin. J Histochem Cytochem. 1997;45(6):837-46.
48. Bomberger RA, Zarins CK, Taylor KE, Glagov S. Effect of hypotension on atherogenesis and aortic wall composition. J Surg Res. 1980;28:402-9.
49. Lee RM. Vascular changes at the prehypertensive phase in the mesenteric arteries from spontaneously hypertensive rats. Blood Vessels. 1985;22(3):105-26. Epub 1985/01/01.
50. Mulvany MJ, Baandrup U, Gundersen HJG. Evidence for hyperplasia in mesenteric resistance vessels of spontaneously hypertensive rats using a threedimensional dissector. Circ Res. 1985;57:794-800.
51. Sehgel NL, Zhu Y, Sun Z, Trzeciakowski JP, Hong Z, Hunter WC, et al. Increased vascular smooth muscle cell stiffness; a novel mechanism for aortic stiffness in hypertension. Am J Physiol Heart Circ Physiol. 2013;305:H1281-7.
52. Olsen MH, Christensen MK, Wachtell K, Tuxen C, Fossum E, Bang LE, et al. Markers of collagen synthesis is related to blood pressure and vascular hypertrophy: a LIFE substudy. J Hum Hypertens. 2005;19(4):301-7.
53. Jones PL, Cowan KN, Rabinovitch M. Tenascin-C, proliferation and subendothelial fi bronectin in progressive pulmonary vascular disease. Am J Pathol. 1997;150(4):1349-60. Epub 1997/04/01.
54. Hahn AW, Kern F, Jonas U, John M, Buhler FR, Resink TJ. Functional aspects of vascular tenascin-C expression. J Vasc Res. 1995;32(3):162-74. Epub 1995/05/01.
55. Jones PL, Crack J, Rabinovitch M. Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth. J Cell Biol. 1997;139(1):279-93. Epub 1997/10/06.
56. Fogerty FJ, Akiyama SK, Yamada KM, Mosher DF. Inhibition of binding of fi bronectin to matrix assembly sites by anti-integrin (alpha 5 beta 1) antibodies. J Cell Biol. 1990;111(2):699-708. Epub 1990/08/01.
57. Mercurius KO, Morla AO. Inhibition of vascular smooth muscle cell growth by inhibition of fi bronectin matrix assembly. Circ Res. 1998;82(5):548-56. Epub 1998/04/07.
58. Liaw L, Almeida M, Hart CE, Schwartz SM, Giachelli CM. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res. 1994;74(2):214-24. Epub 1994/02/01.
59. Gadeau AP, Campan M, Millet D, Candresse T, Desgranges C. Osteopontin overexpression is associated with arterial smooth muscle cell proliferation in vitro. Arterioscler Thromb. 1993;13(1):120-5. Epub 1993/01/01.
60. Yamamoto M, Aoyagi M, Azuma H, Yamamoto K. Changes in osteopontin mRNA expression during phenotypic transition of rabbit arterial smooth muscle cells. Histochem Cell Biol. 1997;107(4):279-87. Epub 1997/04/01.
61. Emoto N, Onose H, Yamada H, Minami S, Tsushima T, Wakabayashi I. Growth factors increase pericellular proteoglycans independently of their mitogenic effects on A10 rat vascular smooth muscle cells. Int J Biochem Cell Biol. 1998;30(1):47-54. Epub 1998/05/23.
62. Fukuda N, Hu WY, Satoh C, Nakayama M, Kishioka H, Kubo A, et al. Contribution of synthetic phenotype on the enhanced angiotensin II-generating system in vascular smooth muscle cells from spontaneously hypertensive rats. J Hypertens. 1999;17(8):1099-107.
63. Wilson E, Sudhir K, Ives HE. Mechanical strain of rat vascular smooth muscle cells is sensed by specific extracellular matrix/integrin interactions. J Clin Invest. 1995;96:2364-72.
64. Kato H, Suzuki H, Tajima S, Ogata Y, Tominaga T, Sato A, et al. Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells. J Hypertens. 1991;9:17-22.
65. Marchesi C, Paradis P, Schiffrin EL. Role of the reninangiotensin system in vascular infl ammation. Trends Pharmacol Sci. 2008;29(7):367-74. Epub 2008/06/27.
66. Schiffrin EL, Park JB, Intengan HD, Touyz RM. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation. 2000;101(14):1653-9. Epub 2000/04/12.
67. Park JB, Intengan HD, Schiffrin EL. Reduction of resistance artery stiffness by treatment with the AT(1)-receptor antagonist losartan in essential hypertension. J Renin Angiotensin Aldosterone Syst. 2000;1(1):40-5. Epub 2002/04/23.
68. Zou Y, Akazawa H, Qin Y, Sano M, Takano H, Minamino T, et al. Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II. Nat Cell Biol. 2004;6(6):499-506.
69. Ramkhelawon B, Rivas D, Lehoux S. Shear stress activates extracellular signal-regulated kinase 1/2 via the angiotensin II type 1 receptor. FASEB J. 2013;27(8):3008-16. Epub 2013/04/16.
70. Lemarie CA, Esposito B, Tedgui A, Lehoux S. Pressure-induced vascular activation of nuclear factor-kappaB: role in cell survival. Circ Res. 2003;93(3):207-12.
71. Lemarie CA, Tharaux PL, Esposito B, Tedgui A, Lehoux S. Transforming growth factor-Alpha mediates nuclear factor kappaB activation in strained arteries. Circ Res. 2006;99(4):434-41.
72. Savoia C, Schiffrin EL. Vascular infl ammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions. Clin Sci (Lond). 2007;112(7):375-84. Epub 2007/02/28.
73. Savoia C, Touyz RM, Amiri F, Schiffrin EL. Selective mineralocorticoid receptor blocker eplerenone reduces resistance artery stiffness in hypertensive patients. Hypertension. 2008;51(2):432-9. Epub 2008/01/16.
74. Leibovitz E, Ebrahimian T, Paradis P, Schiffrin EL. Aldosterone induces arterial stiffness in absence of oxidative stress and endothelial dysfunction. J Hypertens. 2009;27(11):2192-200. Epub 2009/08/06.
75. Kasal DA, Barhoumi T, Li MW, Yamamoto N, Zdanovich E, Rehman A, et al. T regulatory lymphocytes prevent aldosterone-induced vascular injury. Hypertension. 2012;59(2):324-30. Epub 2011/12/08.